Evan Stein is a Dyslipidemia / Lipid Disorders physician. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 14 Nov 2026
Evan Stein, MD, is profiled from the public federal record. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Dyslipidemia / Lipid Disorders
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
Sponsor: LIB Therapeutics LLC
- Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction
Sponsor: LIB Therapeutics LLC
Industry payments
Updated 13 Nov 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Alkermes, Inc.Program year20214 payments$82,500openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%PCSK9 Inhibitor46.3%Repatha Sureclick100%Part D<11 patientsCholesterol absorption inhibitor29.6%Ezetimibe100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
cardiometabolichealth.org/faculty/evan-stein
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗ - Other
hcplive.com/view/lerodalcibep-efficaciously-reduces-ldl-c-lastingly-and-long-term-with-evan-stein-md-phd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Gregg Fonarow, MD
Ronald Reagan UCLA Medical Center